• KALETRA oral solution that is stored at room
temperature (less than 77°F or 25“C) should be
used within 2 months.
♦ Keep KALETRA away from high heat.
Throw away any medicine that is out of date or that
you no longer need.
Keep KALETRA and all medicines out of the reach
of children.
General information about KALETRA
KALETRA does not cure HIV-1 or AIDS. The long-term
effects of KALETRA are not known at this time. People
taking KALETRA mav still get opportunistic infections
or other conditions that happen with HIV-1 infection.
Some of these conditions are pneumonia, heroes virus
infections, and Mycobacterium avium complex (MAC)
infections.
Medicines are sometimes prescribed for purposes
other than those listed in a Medication Guide. Do not
use KALETRA for a condition for which it was not
, prescribed. Do not give KALETRA to other people, even
if they have the same condition you have, it may harm
them.
This Medication Guide summarizes the most important
information about KALETRA. If you would like more
information, talk with your doctor. You can ask your
pharmacist or doctor for information about KALETRA
that is written for health professionals. For more
information about KALETRA call 1 -800-633-9113 or
go to www.KALETRA.com.
Active ingredient: lopinavir and ritonavir
Inactive ingredients:
KALETRA 200 mg lopinavir and 50 mg ritonavir
tablets; copovidone, sorbitan monolaurate, colloidal
silicon dioxide, and sodium stearyl fumarate. The
film coating contains: hypromellose, titanium dioxide,
polyethylene glycol 400, hydroxypropyl cellulose, talc,
colloidal silicon dioxide, polyethylene glycol 3350,
yellow ferric oxide 172, and polysorbate 80.
KALETRA 100 mg lopinavir and 25 mg ritonavir
tablets: copovidone, sorbitan monolaurate, colloidal
silicon dioxide, and sodium stearyl fumarate. The film
coating contains: polyvinyl alcohol, titanium dioxide,
talc, polytheylene glycol 3350, and yellow ferric oxide
El 72.
KALETRA oral solution: acesulfame potassium,
alcohol, artificial cotton candy flavor, citric acid,
glycerin, high fructose com syrup, Magnasweet-110
flavor, menthol, natural and artificial vanilla flavor,
peppermint oil, polyoxyl 40 hydrogenated castor oil,
povidone, propylene glycol, saccharin sodium, sodium
chloride, sodium citrate, and water.
KALETRA oral solution contains 42.4% alcohol
(v/v). “See How should I take KALETRA?”.
KALETRA Tablets, 200 mg lopinavir/50 mg ritonavir
Manufactured by Abbott Pharmaceuticals PR Ltd.,
Barceloneta,PR00617
for Abbott Laboratories, North Chicago, IL 60064, U.SA
KALETRA Tablets, 100 mg lopinavir/25 mg ritonavir and
KALETRA Oral Solution .
Abbott Laboratories, North Chicago, IL 60064, U.S.A.
2010.ALL RIGHTS RESERVED
* The brands listed are trademarks of their respective
owners and are not trademarks of Abbott Laboratories.
The makers of these brands are not affiliated with and
do not endorse Abbott Laboratories or its products.
This Medication Guide has been approved by the U.S.
Food and Drug Administration.
Ref: 03-A387-R8
Revised: June, 2010
036-395113 MASTER
039-418110
Abbott
10 qnotes Oct. 30-Nov. 12.2010'